Patents by Inventor Futoshi Shibasaki

Futoshi Shibasaki has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160069879
    Abstract: The purpose of this invention is to provide novel methods of measuring concentrations of ?-galactosidase in blood, serum, plasma, cells, or tissues. For solution of this purpose, concentrations of ?-galactosidase are measured using a MUSTag method in the blood, serum, plasma, cells, or tissues.
    Type: Application
    Filed: November 27, 2013
    Publication date: March 10, 2016
    Inventors: Hitoshi SAKURABA, Futoshi SHIBASAKI, Sachie NAKANO
  • Publication number: 20130129738
    Abstract: Disclosed is an influenza virus infection inhibitor. Specifically disclosed is a pharmaceutical composition that is composed of an inhibitor such as an antibody which recognizes a peptide comprising the amino acid sequence of RERRRKKR (SEQ ID NO: 1) and inhibits the action of introducing an RR sequence into a cell. The influenza virus infection inhibitor is produced so as to contain the pharmaceutical composition.
    Type: Application
    Filed: November 19, 2010
    Publication date: May 23, 2013
    Applicant: TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE
    Inventors: Futoshi Shibasaki, Akira Sakurai
  • Publication number: 20120115927
    Abstract: Disclosed is a pharmaceutical agent for preventing cell death. The occurrence of cell death can be prevented by inhibiting the function of Int6 protein in an affected area. Then, a pharmaceutical agent comprising a substance capable of inhibiting the function of Int6 protein is prepared. The pharmaceutical agent can be used for preventing cell death.
    Type: Application
    Filed: March 23, 2010
    Publication date: May 10, 2012
    Applicant: TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE
    Inventors: Futoshi Shibasaki, Li Chen
  • Publication number: 20110189690
    Abstract: In order to improve the detection sensitivity of MUSTag, the present invention provides an antibody complex including a nucleic acid chain as a label, an antibody to specifically recognize the antigen and an adaptor moiety linking the nucleic acid chain and the antibody, wherein the adaptor moiety includes an immunoglobulin binding domain of Protein G, Protein A or Protein L for binding with the antibody, and the adaptor moiety and the antibody are chemically cross-linked to form a cross-linked antibody complex.
    Type: Application
    Filed: June 30, 2009
    Publication date: August 4, 2011
    Applicants: TOKYO METROPOLITAN ORGANIZATION FOR MEDICAL RESEARCH, SYNTHERA TECHNOLOGIES CO., LTD.
    Inventors: Futoshi Shibasaki, Yoshihito Morizane
  • Publication number: 20080318340
    Abstract: The present invention provides a method for identifying and detecting multiple types of target substances contained in a specimen, comprising the steps of: contacting the target substances immobilized and/or nonimmobilized on a support with labeled binders capable of identifying corresponding types of target substances so as to form complexes between the target substances and the binders; and detecting the labels in the binders forming the complexes.
    Type: Application
    Filed: November 1, 2005
    Publication date: December 25, 2008
    Applicants: TOKYO METROPOLITAN ORGANIZATION FOR MEDICAL RESEAR, SYNTHERA TECHNOLOGIES CO., LTD.
    Inventors: Futoshi Shibasaki, Kazuhiko Sakata
  • Publication number: 20040033946
    Abstract: A composition for inhibiting cell damage comprising FR901459 Substance as following formula (I) or its salt in admixture with pharmaceutically acceptable carriers or excipients.
    Type: Application
    Filed: August 4, 2003
    Publication date: February 19, 2004
    Inventors: Futoshi Shibasaki, Hiroyuki Uchino, Motohiro Hino, Hirohisa Nakada